BHVN: Gentile Kimberly discloses securities transactions

By AlphaYouPublished Sep 17, 2026Form 4

Stocks in this disclosure

Reported activity

Gentile Kimberly

Reporting filer

Gentile Kimberly reported Grant or award in Biohaven Ltd.: 1000 units of Stock Options (Right to buy) (derivative), dated 2026-09-15. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 17, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Options (Right to buy) (derivative)	Gentile Kimberly	2026-09-15	A	Grant or award	1000	0	1,000	2 days	Filed terms security Title: Stock Options (Right to buy) conversion Or Exercise Price: 12.34 transaction Date: 2026-09-15 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 1000 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-09-15 underlying Security Title: Common Shares underlying Security Shares: 1000 shares Owned Following Transaction: 1000 id: F2 direct Or Indirect Ownership: I nature Of Ownership: By Son

Stock Options (Right to buy) (derivative)

Owner: Gentile Kimberly
Date: 2026-09-15
Code: A
Action: Grant or award
Quantity: 1000
Price: 0
Following holdings: 1,000
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Stock Options (Right to buy)
conversion Or Exercise Price: 12.34
transaction Date: 2026-09-15
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 1000
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-15
underlying Security Title: Common Shares
underlying Security Shares: 1000
shares Owned Following Transaction: 1000
id: F2
direct Or Indirect Ownership: I
nature Of Ownership: By Son

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Gentile Kimberly: SVP, Clinical Operations.
F1: The shares underlying this option vest in four equal installments on September 15, 2026, 2027, 2028 and 2029, subject to the Reporting Person's son's continuous service with the Issuer at each vesting date.
F2: Represents a stock option granted to the Reporting Person's son in connection with the commencement of his employment with the Issuer. The Reporting Person disclaims beneficial ownership of all securities held by her son, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Stock Options (Right to buy) (derivative)

Gentile Kimberly

2026-09-15

Grant or award

1000

1,000

2 days

Filed terms

security Title: Stock Options (Right to buy)
conversion Or Exercise Price: 12.34
transaction Date: 2026-09-15
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 1000
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-15
underlying Security Title: Common Shares
underlying Security Shares: 1000
shares Owned Following Transaction: 1000
id: F2
direct Or Indirect Ownership: I
nature Of Ownership: By Son

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Gentile Kimberly: SVP, Clinical Operations.

F1: The shares underlying this option vest in four equal installments on September 15, 2026, 2027, 2028 and 2029, subject to the Reporting Person's son's continuous service with the Issuer at each vesting date.

F2: Represents a stock option granted to the Reporting Person's son in connection with the commencement of his employment with the Issuer. The Reporting Person disclaims beneficial ownership of all securities held by her son, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.